Michela Gallagher | |
|---|---|
 Gallagher speaks to the National Institute on Aging in 2017 | |
| Alma mater | University College London, Colgate University, University of Vermont |
| Awards | Mika Salpeter Lifetime Achievement Award |
| Scientific career | |
| Institutions | University of North Carolina–Chapel Hill, Johns Hopkins University, AgeneBio |
| Thesis | The effects of norepinephrine manipulations in the amygdala on time-dependent memory processes (1977) |
Michela Gallagher is an American cognitive psychologist and neuroscientist. She is the Krieger-Eisenhower Professor of Psychology and Neuroscience at Johns Hopkins University. Her scientific work has changed the model of neurocognitive aging, and developed new indices for its study. Previously, work had focused on neurodegeneration as a primary cause of memory loss.
Gallagher's research suggests that age-related declines in cognition may also occur in the absence of neurodegeneration, due to malfunctioning rather than dying off. Gallagher is also the founder and CEO of AgeneBio, a company which aims to develop a cure for Alzheimer's disease.